Managing Your Environmental Isolates

Size: px
Start display at page:

Download "Managing Your Environmental Isolates"

Transcription

1 Managing Your Environmental Isolates

2 Good Testing Practices Good practice includes the periodic challenge of media with low levels of organisms. This includes USP indicator organisms as well as normal flora. -U.S. Food and Drug Administration: Guide to Inspections of Microbiological Pharmaceutical Quality Control Laboratories (1993)

3 Detection & Identification It is important to know: What is in the cleanroom environment The effectiveness of cleaning and sanitization procedures The source of the contaminate

4 Sources of Contamination Personnel Utilities Raw Materials Facility Equipment Common culprits: Personnel Air Water Processes Case Studies of Microbial Contamination in Biologic Product Manufacturing Suvama, et al., American Pharmaceutical Review, Processes

5 Tracking and Trending Effective tracking and trending analysis is essential An early warning signal for system failures Provides clues to contamination source

6 Is It Objectionable? 21 CFR (d)(6) Each lot of a component, drug product container, or closure with potential for microbiological contamination that is objectionable in view of its intended use shall be subjected to microbiological tests before use. 21 CFR (a) Appropriate written procedures, designed to prevent objectionable microorganisms in drug products not required to be sterile, shall be established and followed. 21 CFR (b) There shall be appropriate laboratory testing, as necessary, of each batch of drug product required to be free of objectionable microorganisms. What is an Objectionable Organism? Sutton, Scott, Ph.D., American Pharmaceutical Review, October 2012.

7 Is It Objectionable? Ultimately, the laboratory must determine if the organism is objectionable Sterile vs. non-sterile products Intended use Intended recipient Intended route of administration

8 Managing Risk with Testing Disinfectant Challenge Test Growth Promotion Test Antimicrobial Effectiveness Test

9 Disinfectant Challenge Testing the most frequently isolated microorganisms from an environmental monitoring program may be periodically subjected to use-dilution testing with the agents used in the disinfection program to confirm their susceptibility, as there are real differences among different species in resistance to the lethal effects of different sanitizers. USP 38 <1072> Disinfectants and Antiseptics, 2015

10 Selecting the Right Isolates for Disinfectant Testing Provide scientific rationale for the organisms used for your testing Choose strains that represent common organisms isolates from the facility Choose organisms that are common contaminates or high risk for the products manufactured at the facility Avoid unnecessary audit findings

11 Growth Promotion Testing The media used in the following tests should be capable of growing recommended indicator organisms and environmental isolates Environmental monitoring Media fills Sterility Test

12 Growth Promotion Testing The growth promotion test is a procedure used to demonstrate the media in the microbiological environmental monitoring program or in media-fill runs, are capable of supporting growth of indicator microorganism and of environmental isolates from samples obtained through the monitoring program or their corresponding ATCC strains. USP 38 <1116> Aseptic Processing Environments, 2015

13 Antimicrobial Effectiveness Testing The standard battery of challenge organisms need not prevent the inclusion of other species of microorganisms if deemed useful to measure the biological activity of the preservative system for a specific product. USP <51> Antimicrobial Effectiveness Testing, 2015 Product Product

14 Antimicrobial Effectiveness Testing Products of any category whose formulas establish more extreme environmental conditions (ph, water activity, specific formula conditions) may warrant addition of isolates capable of survival if not growth under such extreme conditions allowing measure of preservative efficacy versus intrinsic hostility. Antimicrobial Effectiveness Testing: Culture Selection and Inoculum Preparation, Phil Geiss, 2013

15 Why Use Environmental Isolates? Environmental isolates may be more resistant to disinfectants because they adapt to the environment and limited nutrients The isolates may need special conditions to grow Isolates can be harder to detect in your product

16 Wild Strains versus Domesticated Strains Wild microorganisms are able to modify their properties according to their nutrient supply (for example, phase variation in bacteria) and, in particular, are able to adapt to limited nutrients. Multicellular microorganisms: laboratory versus nature, Zdena Palková, EMBO Reports, 2004 There is a strong argument that environmental isolates are the best challenge to media and for validation studies like sterility test validation. They are the most sensitive microorganisms, having become recently exposed to disinfectants, particular soils etc. The Use of Environmental Isolates, Tim Sandle, Pharmaceutical Microbiology blog, January 10, 2010

17 Preserving Isolate Options Professional Preservation Services Long-Term Preservation Methods Short-Term Preservation Methods

18 Short-Term Preservation Methods Preservation Method Pros Cons Sub-culturing/ Refrigeration + Low tech - Highest risk of mutation - Risk of contamination - Must remain within 5 passages per USP Sub-zero Freezing (-20 C) + Viability can be maintained for 1-2 yrs. - Ice crystals and electrolyte fluctuations can damage organism - Risk of contamination - Freezer cost and maintenance

19 Long-Term Preservation Methods Preservation Method Ultra-low Freezing Cryogenic Freezing Pros + Reduces probability of mutation + Longer survival rate Cons - Labor intensive - Costly - Must closely monitor temperature - Vulnerable to power outages and failures Lyophilization + Reduced risk of intracellular ice crystallization; halts all enzymatic and non-enzymatic reactions + Easy storage - Requires specialized equipment - Labor intensive - Experimentation required; strains react differently to process

20 Professional Preservation Services Turn-key processes for isolate management Isolate identification Isolate manufacturing Isolate storage Characterizatio n and seed preparation Customized format production Shipping, distribution and storage

21 Step 1: Characterization and Preproduction Strain characterization Determine final isolate specifications for testing Media and conditions should be mimicked Packaging needs Distribution requirements Establish a project timeline

22 Step 2: Production Seed stock is established 3-phase quality control checks Before preservation After preservation After packaging Seed stock for storage and future use Stock for immediate production

23 Step 3: Certificates and Reports Certificate of Analysis Mean Assay Value and statistics Complete DNA sequencing report Organisms identification Biochemical testing results

24 Step 4: Shipping and Storage Isolate is packaged, shipped and distributed Isolates are maintained for future use

25 Cost Analysis for Outsourcing Costs of Manual Prep Labor (hrs x wages) - Handling isolates - Quantitating samples - Identification for mutation - QC for contamination - Record keeping for audits Freezer 3 rd party identification Laboratory supplies Higher Cost Vs. Costs of Outsourcing Project price Identification (included) Maintenance & storage (included) Lower Cost

26 Considerations for Outsourcing Accreditation Experience Test-ready format options Quality reputation Finished goods storage Technical support and service Distribution options Product warranty

27 Final Thoughts All environmental isolates pose risk in aseptic manufacturing Current regulations require the use of isolates in testing Managing isolates can be difficult and expensive, but there are accredited providers to help

28 Contact Info Kelly Hedlund Midwest Regional Sales Manager Territory - IL, IN, MI, MN, ND, OH, WI Cell: khedlund@microbiologics.com Website:

29 Thank you!

Managing Your Environmental Isolates

Managing Your Environmental Isolates Managing Your Environmental Isolates The Controversy Good practice includes the periodic challenge of prepared media with low levels of organisms. This includes USP indicator organisms as well as normal

More information

Robert Westney, M.S., RAC, CMQ/OE Director of Quality and Operations Cryologics, Inc. March 7, 2017

Robert Westney, M.S., RAC, CMQ/OE Director of Quality and Operations Cryologics, Inc. March 7, 2017 Robert Westney, M.S., RAC, CMQ/OE Director of Quality and Operations Cryologics, Inc. March 7, 2017 1 About the Presenter Bob Westney, M.S. QA/RA, RAC, CMQ/OE 30 years of industry experience QC Microbiology,

More information

Quality Control Microorganism Product Guide. Convenience with Confidence

Quality Control Microorganism Product Guide. Convenience with Confidence Quality Control Microorganism Product Guide Convenience with Confidence LYFO DISK For Culture Purposes and Quality Control Applications LYFO DISK lyophilized pellets contain a single microorganism strain

More information

FDA s Guidance for Industry

FDA s Guidance for Industry Sterile Drug Products Produced by Aseptic Processing - CGMPs Midwest FDC Conference November 4 2005 Susan Bruederle, Investigator FDA / ORA / Central Region Chicago District / Hinsdale IL FDA s Guidance

More information

Subpart B Organization and Personnel, 21 CFR Responsibilities of the quality control unit.

Subpart B Organization and Personnel, 21 CFR Responsibilities of the quality control unit. FDA inspections continue to focus on CGMP violations related to basic GMP controls. A survey of Warning Letters issued in 2013 on CMC (Chemistry / Manufacturing / Controls) violations reveals an emphasis

More information

Microbiology Testing: USP requirements for Sterile and Nonsterile Preparations Webinar Q&A

Microbiology Testing: USP requirements for Sterile and Nonsterile Preparations Webinar Q&A USP Antimicrobial Effectiveness Testing Microbiology Testing: Webinar Q&A 1. If a base ingredient is designed for the purpose of compounding a specific type of preparation does this forgo the necessity

More information

Hot Topics in Drug Product Process Validation: A Reviewer s Perspective

Hot Topics in Drug Product Process Validation: A Reviewer s Perspective Hot Topics in Drug Product Process Validation: A Reviewer s Perspective Colleen Thomas, Ph.D. Quality Assessment Lead (Acting) FDA/CDER/OPQ/OPF Division of Microbiology Assessment CASSS CMC Strategy Forum

More information

Why Do I Test, What Do I Test & When Do I Test It? Ross Caputo, PhD Chief Technical Officer Eagle Analytical Services

Why Do I Test, What Do I Test & When Do I Test It? Ross Caputo, PhD Chief Technical Officer Eagle Analytical Services Why Do I Test, What Do I Test & When Do I Test It? Ross Caputo, PhD Chief Technical Officer Eagle Analytical Services Disclosures I, Ross Caputo, declare no conflicts of interest, real or apparent, and

More information

MICROBIOLOGICAL CULTURE MEDIA

MICROBIOLOGICAL CULTURE MEDIA MICROBIOLOGICAL CULTURE MEDIA A COMPLETE GUIDE FOR PHARMACEUTICAL AND HEALTHCARE MANUFACTURERS Tim Sandle Microbiological Culture Media: A Complete Guide for Pharmaceutical and Healthcare Manufacturers

More information

INSTRUCTIONS FOR USE

INSTRUCTIONS FOR USE INSTRUCTIONS FOR USE Epower Microorganisms INTENDED USE Epower microorganisms are lyophilized, quantitative microorganism preparations to be used in industrial laboratories for quality control purposes.

More information

Preparing Your Aseptic Processing Facility for an FDA Inspection. Valerie Welter, Director Quality Bayer HealthCare March 10, 2014

Preparing Your Aseptic Processing Facility for an FDA Inspection. Valerie Welter, Director Quality Bayer HealthCare March 10, 2014 Preparing Your Aseptic Processing Facility for an FDA Inspection Valerie Welter, Director Quality Bayer HealthCare March 10, 2014 Agenda Regulatory Requirements Establishing your Approach Aseptic Controls

More information

LUNCH AND LEARN. September 11, CE Activity Information & Accreditation

LUNCH AND LEARN. September 11, CE Activity Information & Accreditation LUNCH AND LEARN Environmental Monitoring and Contamination Control September 11, 2015 Featured Speaker: Scott Sutton, Ph.D. The Microbiology Network N. Chili, New York 1 CE Activity Information & Accreditation

More information

Q8 Pharmaceutical Development

Q8 Pharmaceutical Development Q8 Pharmaceutical Development For questions regarding this draft document contact (CDER) Ajaz Hussain at 301-594-2847 or (CBER) Christopher Joneckis at 301-435-5681. This draft guidance, when finalized,

More information

DISINFECTION QUALIFI CATION TESTING CONSIDERATIONS FOR THE ASEPTIC AND CLEANROOM MANUFACTURING ENVIRONMENT

DISINFECTION QUALIFI CATION TESTING CONSIDERATIONS FOR THE ASEPTIC AND CLEANROOM MANUFACTURING ENVIRONMENT DISINFECTION QUALIFI CATION TESTING CONSIDERATIONS FOR THE ASEPTIC AND CLEANROOM MANUFACTURING ENVIRONMENT by Dave Rottjakob, M.T. (ASCP) December, 2013 INTRODUCTION Obtaining the highest confidence that

More information

How to Handle Excursions in Environmental Monitoring (EM) and Personnel Monitoring (PM) in an Aseptic Processing Plant

How to Handle Excursions in Environmental Monitoring (EM) and Personnel Monitoring (PM) in an Aseptic Processing Plant How to Handle Excursions in Environmental Monitoring (EM) and Personnel Monitoring (PM) in an Aseptic Processing Plant Randy Hutt, Ph.D. Associate Director Sterility Assurance and Microbiology Luitpold

More information

Residue removal in Cleanroom Environments

Residue removal in Cleanroom Environments Residue removal in Cleanroom Environments PDA Midwest Indianapolis Event 06 Oct 2016 Contamination Control Solutions 1/ BIO Beth Kroeger Technical Service Manager STERIS Life Sciences 4 years 24 years

More information

Today s Topics. General Quality Control Best Practices. Practices Antimicrobial Effectiveness Testing(AET) Best Practices Environmental Isolates

Today s Topics. General Quality Control Best Practices. Practices Antimicrobial Effectiveness Testing(AET) Best Practices Environmental Isolates Laboratory Best Practices in QC Microbiology Today s Topics General Quality Control Best Practices Growth Promotion Testing (GPT) Best Practices Antimicrobial Effectiveness Testing(AET) Best Practices

More information

Bioburden Contamination Control: A Holistic Overview

Bioburden Contamination Control: A Holistic Overview Bioburden Contamination Control: A Holistic Overview Scott Sutton, PhD Microbiology Network, Inc. Scott Sutton, PhD is the Principal of Microbiology Network, Inc (http:// microbiologynetwork.com/) a company

More information

USP <1116> and Contamination

USP <1116> and Contamination USP and Contamination Recovery Rates Scott Sutton ABSTRACT United States Pharmacopeia (USP) "Microbiological Control and Monitoring of Aseptic Processing Environments" approaches analysis

More information

PROCESS VALIDATION ROCHAPON WACHAROTAYANKUN, PH.D.

PROCESS VALIDATION ROCHAPON WACHAROTAYANKUN, PH.D. Basic GMP Requirement PROCESS VALIDATION ROCHAPON WACHAROTAYANKUN, PH.D. Topic Process validation What and Why? Principle of process validation Manufacturing process validation Aseptic process validation

More information

Overview of Inspection Issues with Legacy Products

Overview of Inspection Issues with Legacy Products Overview of Inspection Issues with Legacy Products Presented by Simone E. Pitts Consumer Safety Officer, USFDA Team Biologics simone.pitts@fda.hhs.gov Objective To provide some examples of recent inspectional

More information

INSTRUCTIONS FOR USE

INSTRUCTIONS FOR USE INSTRUCTIONS FOR USE EZ-Accu Shot Microorganisms EZ-Accu Shot Select Microorganisms INTENDED USE EZ-Accu Shot and EZ-Accu Shot Select microorganisms are lyophilized, enumerated microorganism preparations

More information

Avoid recurrent microbial contamination using trending of historical data. El Azab Walid Technical Service Manager STERIS

Avoid recurrent microbial contamination using trending of historical data. El Azab Walid Technical Service Manager STERIS Avoid recurrent microbial contamination using trending of historical data El Azab Walid Technical Service Manager STERIS Agenda Factors influencing the cleaning and disinfection performance Recurring microbial

More information

Media Fill A Process Simution. Presented By Shikha Chauhan

Media Fill A Process Simution. Presented By Shikha Chauhan Media Fill A Process Simution Presented By Shikha Chauhan 21 CFR 211.113 Validation of Aseptic Processing and Sterilization Process Simulation / Media Fill Filtration Efficacy Sterilization of Equipment,

More information

ATCC Microbiology Best Practices for Stock Maintenance. C a r o l H o r t o n M a r ke t i n g M a n a g e r, AT C C

ATCC Microbiology Best Practices for Stock Maintenance. C a r o l H o r t o n M a r ke t i n g M a n a g e r, AT C C ATCC Microbiology Best Practices for Stock Maintenance C a r o l H o r t o n M a r ke t i n g M a n a g e r, AT C C About ATCC Founded in 1925, ATCC is a non-profit organization with headquarters in Manassas,

More information

Complaints Investigations Root Cause Analysis

Complaints Investigations Root Cause Analysis Complaints Investigations Root Cause Analysis Dr. Ademola Daramola International Relations Specialist Drugs US FDA India Office New Delhi February 22nd 2018 Information presented in this presentation does

More information

Disinfection Qualification Testing

Disinfection Qualification Testing Disinfection Qualification Testing Considerations for Aseptic & Cleanroom Manufacturing Environments White Paper Considerations for Aseptic and Cleanroom Manufacturing Environments Obtaining the highest

More information

Microbiological Cleaning Method Validation

Microbiological Cleaning Method Validation Microbiological Cleaning Method Validation The purpose of cleaning procedures should never be to reduce bioburden to an acceptable level! Fergus O Connell QA Manager Eurofins ams Laboratories www.eurofins.com

More information

The Microbiological Requirements of a Stability Study. Ngoc Anh-Thu Phan 19 th June 2012

The Microbiological Requirements of a Stability Study. Ngoc Anh-Thu Phan 19 th June 2012 The Microbiological Requirements of a Stability Study Ngoc Anh-Thu Phan 19 th June 2012 Contents Introduction Harmonized Tests Acceptance Criteria Selection of Tests Why PE Testing? Selection of Category

More information

EZ-CFU Microorganisms

EZ-CFU Microorganisms EZ-CFU Microorganisms The EZ-CFU Microorganism preparations provide quantitative challenges for mandated Pharmacopeial applications. INTENDED USE EZ-CFU Microorganisms are lyophilized, quantitative microorganism

More information

WHO GUIDELINE Stability testing of active pharmaceutical ingredients and finished pharmaceutical products

WHO GUIDELINE Stability testing of active pharmaceutical ingredients and finished pharmaceutical products WHO GUIDELINE Stability testing of active pharmaceutical ingredients and finished pharmaceutical products 1. Introduction 1.1 Objectives of these guidelines 1.2 Scope of these guidelines 1.3 General principles

More information

USP Chapter 823 USP 32 (old) vs. USP 35 (new)

USP Chapter 823 USP 32 (old) vs. USP 35 (new) USP Chapter 823 USP 32 (old) vs. USP 35 (new) Sally W. Schwarz, MS, BCNP Research Associate Professor of Radiology Washington University School of Medicine St. Louis, MO Why USP Chapter ? FDA has

More information

Providing clear solutions to microbiological challenges TM. cgmp/iso CLIA. Polyphasic Microbial Identification & DNA Fingerprinting

Providing clear solutions to microbiological challenges TM. cgmp/iso CLIA. Polyphasic Microbial Identification & DNA Fingerprinting Providing clear solutions to microbiological challenges TM Cert. No. 2254.01 Polyphasic Microbial Identification & DNA Fingerprinting Microbial Contamination Tracking & Trending cgmp/iso-17025-2005 CLIA

More information

Extending Beyond Use Dating for Compounded Preparations Webinar Q&A

Extending Beyond Use Dating for Compounded Preparations Webinar Q&A Stability Studies 1. If potency over time studies are not acceptable to extend BUD, then why is it offered? Potency point-in-time studies only indicate the potency of a compounded preparation at that specific

More information

Extending Beyond Use Dating for Compounded Preparations Webinar Q&A

Extending Beyond Use Dating for Compounded Preparations Webinar Q&A Stability Studies 1. If potency over time studies are not acceptable to extend BUD, then why is it offered? Potency point-in-time studies only indicate the potency of a compounded preparation at that specific

More information

Guidance for Industry

Guidance for Industry Guidance for Industry for the Submission Documentation for Sterilization Process Validation in Applications for Human and Veterinary Drug Products Center for Drug Evaluation and Research (CDER) Center

More information

Chapter 9 Controlling Microbial Growth in the Environment. 10/1/ MDufilho

Chapter 9 Controlling Microbial Growth in the Environment. 10/1/ MDufilho Chapter 9 Controlling Microbial Growth in the Environment 10/1/2017 1 MDufilho Table 91 Terminology of Microbial Control 10/1/2017 MDufilho 2 Number of living microbes Figure 91 A plot of microbial death

More information

INSTRUCTIONS FOR USE. EZ-CFU Microorganisms INTENDED USE FORMULA COMPONENTS

INSTRUCTIONS FOR USE. EZ-CFU Microorganisms INTENDED USE FORMULA COMPONENTS INSTRUCTIONS FOR USE EZ-CFU Microorganisms INTENDED USE EZ-CFU microorganisms are lyophilized, enumerated microorganism preparations to be used in industrial laboratories for quality control purposes.

More information

EU Guidance / Q&A. Greg McGurk, GMP Manager (acting) GMP Conference. 7 February 2017 Dublin

EU Guidance / Q&A. Greg McGurk, GMP Manager (acting) GMP Conference. 7 February 2017 Dublin EU Guidance / Q&A Greg McGurk, GMP Manager (acting) GMP Conference 7 February 2017 Dublin TPN Manufacture Q&A TPN Guidance Proposed at IWG that working group be formed to draft guidance Several adverse

More information

Change Control Overview

Change Control Overview Change Control Overview Kelly Thomas Atlantic Technical and Validation Services Copyright 2014 by Atlantic Technical and Validation Services, LLC. 1 Session Outline Discuss Regulations Governing Change

More information

Contact details: Anna Silvani

Contact details: Anna Silvani Consultation Document Good Manufacturing Practice for Advanced Therapy Medicinal Products MolMed comments to the DG SANTE consultation on GMPs for ATMPs pursuant to Article 5 of Regulation 1394/2007. MolMed

More information

Preservative Testing Choice of Challenge Isolates

Preservative Testing Choice of Challenge Isolates Preservative Testing Choice of Challenge Isolates By Dr. Philip Geis "What you see is that the most outstanding feature of life's history is a constant domination by bacteria."~stephen Jay Gould An effective

More information

Microbiological Consideration for Non-Sterile Pharmaceutical

Microbiological Consideration for Non-Sterile Pharmaceutical May 1-3, 2012 Javits Center New York, NY Microbiological Consideration for Non-Sterile Pharmaceutical Dr. Leonard W. Mestrandrea Principal Consultant MESTRANDREA CONSULTING LLC Title Date Microbial Control

More information

INSTRUCTIONS FOR USE LYFO DISK KWIK-STIK KWIK-STIK PLUS. n LYFO DISK Microorganisms n KWIK-STIK Microorganisms n KWIK-STIK Plus Microorganisms

INSTRUCTIONS FOR USE LYFO DISK KWIK-STIK KWIK-STIK PLUS. n LYFO DISK Microorganisms n KWIK-STIK Microorganisms n KWIK-STIK Plus Microorganisms INSTRUCTIONS FOR USE n LYFO DISK Microorganisms n KWIK-STIK Microorganisms n KWIK-STIK Plus Microorganisms LYFO DISK INTENDED USE LYFO DISK, KWIK-STIK and KWIK-STIK Plus Microorganisms are lyophilized,

More information

How to Select a Microbiology Contract Testing Laboratory? Tony Cundell, Ph. D. Microbiological Consulting, LLC Scarsdale, New York

How to Select a Microbiology Contract Testing Laboratory? Tony Cundell, Ph. D. Microbiological Consulting, LLC Scarsdale, New York How to Select a Microbiology Contract Testing Laboratory? Tony Cundell, Ph. D. Microbiological Consulting, LLC Scarsdale, New York June 13, 2017 IVT Microbiology Week 1 Presentation Overview Rationale

More information

Guidance. Media Fills for Validation of Aseptic Preparations for Positron Emission Tomography (PET) Drugs DRAFT GUIDANCE

Guidance. Media Fills for Validation of Aseptic Preparations for Positron Emission Tomography (PET) Drugs DRAFT GUIDANCE Guidance Media Fills for Validation of Aseptic Preparations for Positron Emission Tomography (PET) Drugs DRAFT GUIDANCE This guidance document is being distributed for comment purposes only. Comments and

More information

Inspections, Compliance, Enforcement, and Criminal Investigations

Inspections, Compliance, Enforcement, and Criminal Investigations Seite 1 von 10 Inspections, Compliance, Enforcement, and Criminal Investigations Laboratoire Atlas Inc. 6/25/09 hhsbluebird Department of Health and Human Services Public Health Service Food and Drug Administration

More information

Disinfectant Qualification A Multifaceted Study

Disinfectant Qualification A Multifaceted Study Disinfectant Qualification A Multifaceted Study In this article, Ziva Abraham, Microrite, Inc., gives us a brief overview of the disinfectant qualification study process. An effective cleaning and disinfection

More information

STABILITY TESTING OF NEW DRUG SUBSTANCES AND PRODUCTS

STABILITY TESTING OF NEW DRUG SUBSTANCES AND PRODUCTS INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE STABILITY TESTING OF NEW DRUG SUBSTANCES AND PRODUCTS

More information

ISO 13485:2016 The Final Countdown

ISO 13485:2016 The Final Countdown ISO 13485:2016 The Final Countdown 03 April 2018 Robert G. Ruff Executive Director, Medical Device Certification and Training 1 This document is intended to facilitate an oral briefing. It is not intended

More information

A Case Study for an Improved Approach to Cleanroom Disinfection, Minimizing the Impact and Reducing Downtime

A Case Study for an Improved Approach to Cleanroom Disinfection, Minimizing the Impact and Reducing Downtime A Case Study for an Improved Approach to Cleanroom Disinfection, Minimizing the Impact and Reducing Downtime James Tucker Global Scientific Affairs Manager Ecolab Life Science A Case Study for an Improved

More information

The University of Jordan

The University of Jordan The University of Jordan Faculty: Pharmacy Department: Pharmaceutics & Pharmaceutical technology Program: Pharmacy & Pharm D Academic Year/ Semester: 2013/2014 Pharmaceutical Microbiology II (Course Number:

More information

Risk based approaches for a sterility assurance application review: a microbiologist s perspective Dr. Yeissa Chabrier Roselló

Risk based approaches for a sterility assurance application review: a microbiologist s perspective Dr. Yeissa Chabrier Roselló Risk based approaches for a sterility assurance application review: a microbiologist s perspective Dr. Yeissa Chabrier Roselló Product Quality Microbiologist Division of Microbiology Assessment Office

More information

Pharmaceutical Compounding Sterile and Nonsterile Preparations. Jeanne Sun, PharmD

Pharmaceutical Compounding Sterile and Nonsterile Preparations. Jeanne Sun, PharmD Pharmaceutical Compounding Sterile and Nonsterile Preparations Jeanne Sun, PharmD Agenda Legal Framework Overview Pharmaceutical Compounding Nonsterile Preparations Pharmaceutical Compounding

More information

Overview of Inspection Issues with Legacy Products. Barbara Breithaupt Consumer Safety Officer

Overview of Inspection Issues with Legacy Products. Barbara Breithaupt Consumer Safety Officer Overview of Inspection Issues with Legacy Products Barbara Breithaupt Consumer Safety Officer 1 Overview of the presentation The role of the Quality Unit will be discussed in the context of the inspection

More information

Case study Microbiological excursion during a phase I PQ of a WFI system. Walid El Azab Technical Service Manager STERIS Life Science

Case study Microbiological excursion during a phase I PQ of a WFI system. Walid El Azab Technical Service Manager STERIS Life Science Case study Microbiological excursion during a phase I PQ of a WFI system Walid El Azab Technical Service Manager STERIS Life Science Agenda Agenda Case study Microbiological excursion Description of the

More information

5.1.1 & Changes started in 2008 and were mainly driven under the Chairmanship of Prof Hans van Doorne 11/10/2017

5.1.1 & Changes started in 2008 and were mainly driven under the Chairmanship of Prof Hans van Doorne 11/10/2017 5.1.1 & 5.1.2 V Iain Fenton-May Chairman Group 1 Methods of Preparation of Sterile Products Changes started in 2008 and were mainly driven under the Chairmanship of Prof Hans van Doorne 1 Methods of Preparation

More information

The Most Probable Number Method and Its Use in QC Microbiology

The Most Probable Number Method and Its Use in QC Microbiology The Most Probable Number Method and Its Use in QC Microbiology Scott Sutton "Microbiology Topics" discusses various topics in microbiology of practical use in validation and compliance. We intend this

More information

Growth Promotion Test Guide for Media Used in Sterility Tests

Growth Promotion Test Guide for Media Used in Sterility Tests Growth Promotion Test Guide for Media Used in Sterility Tests The Sterility Test The purpose of the Sterility Test is to determine if a sample of a pharmaceutical product or component is sterile. A satisfactory

More information

Pharmaceutical Reference Standards: Overview and Role in Global Harmonization

Pharmaceutical Reference Standards: Overview and Role in Global Harmonization Matthew Borer, Ph.D., Advisor Pharmaceutical Reference Standards: Overview and Role in Global Harmonization 3rd DIA China Annual Meeting Beijing, China, 16-18 May, 2011 What is a Pharmaceutical Reference

More information

Phase Appropriate GMPs for IMPs. Presented by: Karen S. Ginsbury For: IFF, October 31, Nov 02, 2017

Phase Appropriate GMPs for IMPs. Presented by: Karen S. Ginsbury For: IFF, October 31, Nov 02, 2017 Phase Appropriate GMPs for IMPs Presented by: Karen S. Ginsbury For: IFF, October 31, Nov 02, 2017 1 Lets start with References https://mhrainspectorate.blog.gov.uk/2016/0 5/20/manufacture-of-investigationalmedicinal-products-frequently-askedquestions/

More information

ADVANCED TESTING LABORATORY

ADVANCED TESTING LABORATORY RESOLVING ISSUES. REDUCING RISK. ADVANCED TESTING LABORATORY PROVIDING PEACE-OF-MIND. ADVANCED TESTING LABORATORY 6954 Cornell Road Cincinnati, OH 45242 513.489.8447 513.489.9291 fax ClientRelations@advancedtesting.net

More information

Cleanroom Contamination including Mould/Fungal contamination

Cleanroom Contamination including Mould/Fungal contamination Cleanroom Contamination including Mould/Fungal contamination Brett Cole. Biosafety Pty Ltd Tuesday 25 th July 2017 1 Cleanroom Contamination including Mould/Fungal contamination: 1. Introduction 2. What

More information

HVAC and Risk Management RACI Meeting 7 th December Agenda. Design. Project Management. Context. Qualification. Construction

HVAC and Risk Management RACI Meeting 7 th December Agenda. Design. Project Management. Context. Qualification. Construction HVAC and Risk Management RACI Meeting 7 th December 2011 Dr Stephen Firmer Asia Pacific Consultants Pty Ltd Agenda Context Project Management Design Construction Qualification Routine Control /Potential

More information

Global Biological Resource Leader

Global Biological Resource Leader Custom Solutions Partner with the Global Biological Resource Leader Since 1925, ATCC has set the standard for the manufacture, characterization, preservation, storage and distribution of biological materials.

More information

Test Method for the Continuous Reduction of Bacterial Contamination on Copper Alloy Surfaces

Test Method for the Continuous Reduction of Bacterial Contamination on Copper Alloy Surfaces Test Method for the Continuous Reduction of Bacterial Contamination on Copper Alloy Surfaces Test Organisms: Staphylococcus aureus (ATCC 6538) Enterobacter aerogenes (ATCC 13048) Pseudomonas aeruginosa

More information

Current Considerations on Chemistry, Manufacturing and Control of Cell Therapy Products (CTPs)

Current Considerations on Chemistry, Manufacturing and Control of Cell Therapy Products (CTPs) Current Considerations on Chemistry, Manufacturing and Control of Cell Therapy Products (CTPs) Wei Wei Ph.D Center for Drug Evaluation, National Medical Products Administration (CDE,NMPA) 2018/12/04 Tokyo

More information

The Application of Pharmaceutical cgmp to Live Bacterial Products. James Harris Business Development Manager

The Application of Pharmaceutical cgmp to Live Bacterial Products. James Harris Business Development Manager The Application of Pharmaceutical cgmp to Live Bacterial Products James Harris Business Development Manager The Objective CMC expectations of a cgmp live bacterial biopharmaceutical project Overview Define

More information

INSTRUCTIONS FOR USE. EZ-CFU One Step Microorganisms INTENDED USE FORMULA COMPONENTS

INSTRUCTIONS FOR USE. EZ-CFU One Step Microorganisms INTENDED USE FORMULA COMPONENTS INSTRUCTIONS FOR USE EZ-CFU One Step Microorganisms INTENDED USE EZ-CFU One Step microorganisms are lyophilized, enumerated microorganism preparations to be used in industrial laboratories for quality

More information

Industry Case Study: A Microbial Investigation of Contamination by Burkholderia multivorans. Jim Klein and Geert Verdonk Merck & Co., Inc.

Industry Case Study: A Microbial Investigation of Contamination by Burkholderia multivorans. Jim Klein and Geert Verdonk Merck & Co., Inc. Industry Case Study: A Microbial Investigation of Contamination by Burkholderia multivorans Jim Klein and Geert Verdonk Merck & Co., Inc. Messages The role of microbiological analysis The role of subject

More information

Industry Perspective on PET Manufacturing Comparison of EU and US

Industry Perspective on PET Manufacturing Comparison of EU and US Standards for Imaging Endpoints and Manufacturing of PET Radiopharmaceuticals Industry Perspective on PET Manufacturing Comparison of EU and US Guidances and associated Regulations Natcher Conference Center

More information

Public Health Consumer Protection Program

Public Health Consumer Protection Program Public Health Consumer Protection Program Date Dear Facility Name Thank you for your interest in developing a Hazard Analysis Critical Control Point (HACCP) plan. When you have compiled your completed

More information

Responding to an FDA 483

Responding to an FDA 483 Responding to an FDA 483 Jim Melancon VP, Associate General Counsel BioScrip, Inc. Marc Stranz, PharmD Healthcare Consultant Disclosure The speakers declare no conflicts of interest or financial interest

More information

January 22, WARNING LETTER CHI-03-09

January 22, WARNING LETTER CHI-03-09 DEPARTMENT OF HEALTH & HUMAN S RVICES Food and Drug Administratio n Chicago District 550 West Jackson Blvd., 15th Floor Chicago, Illinois 6066 1 Telephone : 312-353-586 3 CERTIFIED MAIL RETURN RECEIPT

More information

The aim of antimicrobial efficacy testing (AET) performed during

The aim of antimicrobial efficacy testing (AET) performed during Proposed Method to Evaluate the Microbiological Stability of Cosmetics During Use Nadine Bresciani, Valérie Poulet and Nathalie Collard Anemcoli, Lille, France Raphaél Dugue Laboratoire Midac, Loos, France

More information

Pharmacies and Outsourcing Services

Pharmacies and Outsourcing Services Pharmacies and Outsourcing Services Scott Sutton, PhD scott.sutton@microbiol.org 47 Disclaimer I am making this presentation as an independent agent I am not making this presentation as a representative

More information

The Control of Microbial Growth

The Control of Microbial Growth The Control of Microbial Growth Sepsis refers to microbial contamination. Asepsis is the absence of significant contamination. Aseptic surgery techniques prevent microbial contamination of wounds. Terminology

More information

The Control of Microbial Growth

The Control of Microbial Growth The Control of Microbial Growth Sepsis refers to microbial contamination. Asepsis is the absence of significant contamination. Aseptic surgery techniques prevent microbial contamination of wounds. Terminology

More information

Curriculum Vitae. SENIOR VICE PRESIDENT JAMES P. KULLA Mobile Phone:

Curriculum Vitae. SENIOR VICE PRESIDENT JAMES P. KULLA Mobile Phone: Curriculum Vitae SENIOR VICE PRESIDENT JAMES P. KULLA Mobile Phone: 240.413.3350 Summary of Qualifications Jim has been active in the medical products industry since 1967. Jim founded a company in 1980

More information

Appendix J - Guidelines for the Development of an Environmental Sampling Program

Appendix J - Guidelines for the Development of an Environmental Sampling Program J - 1 Appendix J - Guidelines for the Development of an Environmental Sampling Program Page 1 of 11 J - 2 Table of Contents 1 Purpose... 3 2 Scope... 3 3 Definitions......................................................

More information

Webinar Expert Module 3: GMP Inspections Dupont

Webinar Expert Module 3: GMP Inspections Dupont Webinar Expert Module 3: GMP Inspections Dupont 26 January & 9 February 2018 GOP-Innovations your Partner for Practical Training and e-learning Milenko Pavičić Pharmaceutical microbiologist, trainer, coach

More information

This document is a preview generated by EVS

This document is a preview generated by EVS INTERNATIONAL STANDARD ISO 11930 First edition 2012-04-01 Cosmetics Microbiology Evaluation of the antimicrobial protection of a cosmetic product Cosmétiques Microbiologie Évaluation de la protection antimicrobienne

More information

Human Microbiota: proof of concept to production. Michael van der Horst Process Engineer Technical Operations SynCo Bio Partners B.V.

Human Microbiota: proof of concept to production. Michael van der Horst Process Engineer Technical Operations SynCo Bio Partners B.V. Human Microbiota: proof of concept to production Michael van der Horst Process Engineer Technical Operations SynCo Bio Partners B.V. SynCo Bio Partners B.V. Who we are and what we do Licensed cgmp CMO

More information

Proposed Revision of USP General Chapter Radiopharmaceuticals for Positron Emission Tomography Compounding <823>

Proposed Revision of USP General Chapter Radiopharmaceuticals for Positron Emission Tomography Compounding <823> Proposed Revision of USP General Chapter Radiopharmaceuticals for Positron Emission Tomography Compounding Ravi Ravichandran, Ph.D. Steve Zigler, Ph.D. February 21, 2011 Agenda Rationale for the

More information

LEGAL REQUIREMENTS FOR STABILITY

LEGAL REQUIREMENTS FOR STABILITY BY DR. A.V.PRABHU LEGAL REQUIREMENTS FOR STABILITY 21 CFR 211.166- STABILITY TESTING GMP To assess stability characteristics to determine storage conditions and expiration dates. Written stability program

More information

Contamination Risk Assessment in Aseptic, Non-Sterile and Terminally Sterilized Products March 7 th & 8 th Raleigh, NC

Contamination Risk Assessment in Aseptic, Non-Sterile and Terminally Sterilized Products March 7 th & 8 th Raleigh, NC Contamination Risk Assessment in Aseptic, Non-Sterile and Terminally Sterilized Products March 7 th & 8 th Raleigh, NC Contamination risk levels differ in aseptic, and non-sterile and terminally sterilized

More information

Auditing Your Laboratory for Compliance with the FDA Dietary Supplement GMP s

Auditing Your Laboratory for Compliance with the FDA Dietary Supplement GMP s Tech Tip 0020 With the advent of the cgmp s, the majority of companies are increasing the frequency of their outsourced analytical testing. But the GMPs are just that, Good Manufacturing Practices, and

More information

Contents. Contents (13) 1 Production (23)

Contents. Contents (13) 1 Production (23) 1 Production (23) 1.A Sanitation (27) 1.A.1 Organisational prerequisites (27) 1.A.2 Sources of contamination (28) 1.A.3 Responsibilities and implementation (29) 1.B Personnel hygiene (31) 1.B.1 Clothing

More information

Quality aspects Overview. QP declaration

Quality aspects Overview. QP declaration Quality aspects Overview QP declaration Standards for the quality part of the dossier with focus on: - Materials from animals, nosodes - Proof of microbiological quality, pesticides, heavy metals, organic

More information

FOOD AND DRUGS AUTHORITY

FOOD AND DRUGS AUTHORITY G H A N A FOOD AND DRUGS AUTHORITY GUIDELINES FOR STABILITY TESTING OF ACTIVE PHARMACEUTICAL INGREDIENTS AND FINISHED PHARMACEUTICAL PRODUCTS Document No: FDA/DRI/DER/GL-STP/2013/07 Date of First Adoption:

More information

Preservative Challenge Testing and Compendia: Efficient Efficacy

Preservative Challenge Testing and Compendia: Efficient Efficacy Preservative Challenge Testing and Compendia: Efficient Efficacy October 28, 2014 Leon Nepomniashy Energizer Personal Care Presentation Agenda I. Preservative Efficacy overview The What, The When and The

More information

Guidance for Industry Process Validation: General Principles and Practices; A Contract Manufacturing Organization's Approach

Guidance for Industry Process Validation: General Principles and Practices; A Contract Manufacturing Organization's Approach May -3, 202 Javits Center New York, NY Guidance for Industry Process Validation: General Principles and Practices; A Contract Manufacturing Organization's Approach Sandra Lueken Director of Quality Baxter

More information

Inspection Trends. American Society for Quality Richmond, VA Section March 8, 2016

Inspection Trends. American Society for Quality Richmond, VA Section March 8, 2016 Inspection Trends American Society for Quality Richmond, VA Section March 8, 2016 Brooke K. Higgins, Senior Policy Advisor CDER / Office of Compliance Office of Manufacturing Quality Division of Drug Quality

More information

Packaging Operations Technical Subcommittee

Packaging Operations Technical Subcommittee and Sterile About the Presenter John Derek Thompson Lead Sterile Engineer, DePuy Synthes Certified Professional with the IOPP Member of the Medical Device Technical Committee Chairman of the Member of

More information

CGMP Requirements for Investigational Products

CGMP Requirements for Investigational Products PREP #6 CGMP Requirements for Investigational Products Ji-Eun Kim, RPh, PhD Research Pharmacist Regulatory Affairs Office of Research Compliance December 6, 2016 1 CME Disclosure Statement Northwell Health

More information

Environmental Monitoring of Aseptic Processing Areas - 1

Environmental Monitoring of Aseptic Processing Areas - 1 Environmental Monitoring of Aseptic Processing Areas - 1 A war against an invisible enemy DCVMN - Víctor Maqueda - May 30, 31, June 1 2016 1 Training Course Agenda Overview of Environmental Monitoring

More information

MICROBIOLOGICAL BEST LABORATORY PRACTICES USP <1117>

MICROBIOLOGICAL BEST LABORATORY PRACTICES USP <1117> MICROBIOLOGICAL BEST LABORATORY PRACTICES USP MEDIA PREPARATION AND QUALITY CONTROL MAINTENANCE OF MICROBIOLOGICAL CULTURES LABORATORY EQUIPMENT LABORATORY LAYOUT AND OPERATIONS SAMPLE HANDLING

More information

INTRODUCTION Sanitization sterilization Antibiotics Bactericidal Bacteriostatic Antiseptics disinfectants

INTRODUCTION Sanitization sterilization Antibiotics Bactericidal Bacteriostatic Antiseptics disinfectants INTRODUCTION Infectious agents on environmental surfaces, given the correct circumstances, may potentially find their way into an unsuspecting victim. Thus, it is important to keep the surfaces we regularly

More information

THE GMP HANDBOOK ANNEXES. g o o d m a n u fac t u r i n g p r ac t i c e. quality systems for the pharmaceutical industry.

THE GMP HANDBOOK ANNEXES. g o o d m a n u fac t u r i n g p r ac t i c e. quality systems for the pharmaceutical industry. THE GMP HANDBOOK g o o d m a n u fac t u r i n g p r ac t i c e quality systems for the pharmaceutical industry Ke y2 C om pl ia nc e AB by Anna Lundén ANNEXES Key2Compliance AB Annexes - Content Annexes

More information

The ABCs and Challenges of GMP The American Experience

The ABCs and Challenges of GMP The American Experience The ABCs and Challenges of GMP The American Experience The Canadian Association of Nuclear Medicine Toronto, Ontario April 22, 2017 Reiko Oyama, R.Ph., B.C.N.P. Washington University School of Medicine

More information